|
|
 Previous Article | Table of Contents | Next Article 
Thrombin stimulation of human endothelial cell phospholipase D activity.
Regulation by phospholipase C, protein kinase C, and cyclic adenosine
3'5'-monophosphate
JG Garcia, JW Fenton and V Natarajan
Department of Medicine, Indiana University School of Medicine,
Indianapolis.
The activation of membrane-bound phospholipase D (PLD) resulting in the
generation of phosphatidic acid (PA) is increasingly recognized as an
integral event in the initiation of a variety of cellular responses. We
explored whether alpha-thrombin is a physiologic agonist for PLD activation
in human umbilical vein endothelial cells (HUVEC). HUVEC monolayers were
labeled with [32Pi] and PLD activity determined by formation of the PLD
metabolite [32P] phosphatidylethanol (PEt) in the presence of 5 g/L ethanol
by thin-layer chromatography. alpha-Thrombin rapidly (1 minute) increased
PA and PEt formation in a dose-dependent manner (10(-6) to 10(-10)) with
maximal PLD stimulation achieved with 10 nmol/L alpha-thrombin producing a
threefold to fourfold increase in PA and a sixfold to eightfold increase in
PEt over controls at 15 minutes. Esterolytically active zeta-thrombin (10
nmol/L) and gamma- thrombin (1 mumol/L), but not inactive
DIP-alpha-thrombin (1 mumol/L) also increased PLD activity. The role of
Ca2+ flux in human endothelial cell PLD activation was investigated and PEt
formation was significantly enhanced by Ca2+ ionophores A23187 and
ionomycin (1 mumol/L, three-fold to fourfold increase in PEt).
Alpha-Thrombin- stimulated PEt formation was abolished (greater than 90%
inhibition) with chelation of intracellular calcium (Ca2+i) by pretreatment
with BAPTA-AM (25 mumol/L, 30 minutes) but only mildly attenuated (30%
inhibition) by removal of extracellular calcium (Ca2+E) with EGTA (5
mmol/L). The protein kinase C (PKC) inhibitor staurosporine reduced
alpha-thrombin-induced PEt formation in a dose-dependent manner (10
mumol/L, 78% inhibition) and PKC downregulation with chronic PMA treatment
(18 hours) also resulted in marked inhibition of alpha- thrombin-induced
PEt formation. Neither pertussis nor botulinum C bacterial toxins
significantly altered alpha-thrombin-induced PLD responses. In contrast,
similar pretreatment with cholera toxin (1 microgram/mL, 60 minutes)
consistently augmented alpha-thrombin- stimulated PLD activity by 50% to
90%. Comparable results were observed with agents which increased cAMP such
as forskolin, 8-bromo cAMP, or dibutyryl cAMP and cholera toxin
augmentation was abolished by 2- dideoxyadenosine, a competitive inhibitor
of adenylyl cyclase activity. These studies demonstrate that alpha-thrombin
is a potent stimulus for human PLD-mediated PA formation and that cyclic
adenosine nucleotides modulate agonist-induced cellular PLD activity. In
this model of PLD activation, alpha-thrombin receptor occupancy leads to
the breakdown of phosphatidylinositol 4,5-bisphosphate catalyzed by
phospholipase C producing the Ca2+ secretagogue IP3 and DAG.(ABSTRACT
TRUNCATED AT 400 WORDS)
Volume 79,
Issue 8,
pp. 2056-2067,
04/15/1992
Copyright © 1992 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. A. Birukova, D. Adyshev, B. Gorshkov, G. M. Bokoch, K. G. Birukov, and A. D. Verin
GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction
Am J Physiol Lung Cell Mol Physiol,
March 1, 2006;
290(3):
L540 - L548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kawkitinarong, L. Linz-McGillem, K. G. Birukov, and J. G. N. Garcia
Differential Regulation of Human Lung Epithelial and Endothelial Barrier Function by Thrombin
Am. J. Respir. Cell Mol. Biol.,
November 1, 2004;
31(5):
517 - 527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Minami, A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird
Thrombin and Phenotypic Modulation of the Endothelium
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2004;
24(1):
41 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. SHIKATA, K. G. BIRUKOV, A. A. BIRUKOVA, A. VERIN, and J. G. N. GARCIA
Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT
FASEB J,
December 1, 2003;
17(15):
2240 - 2249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Borbiev, A. D. Verin, A. Birukova, F. Liu, M. T. Crow, and J. G. N. Garcia
Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction
Am J Physiol Lung Cell Mol Physiol,
July 1, 2003;
285(1):
L43 - L54.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Bruckener, A. el Baya, H.-J. Galla, and M. A. Schmidt
Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP
J. Cell Sci.,
May 1, 2003;
116(9):
1837 - 1846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. N. GARCIA, P. WANG, K. L. SCHAPHORST, P. M. BECKER, T. BORBIEV, F. LIU, A. BIRUKOVA, K. JACOBS, N. BOGATCHEVA, and A. D. VERIN
Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability
FASEB J,
July 1, 2002;
16(9):
1064 - 1076.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Natarajan, W. M. Scribner, A. J. Morris, S. Roy, S. Vepa, J. Yang, R. Wadgaonkar, S. P. M. Reddy, J. G. N. Garcia, and N. L. Parinandi
Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 2001;
281(2):
L435 - L449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Borbiev, A. D. Verin, S. Shi, F. Liu, and J. G. N. Garcia
Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II
Am J Physiol Lung Cell Mol Physiol,
May 1, 2001;
280(5):
L983 - L990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. N. Garcia, P. Wang, F. Liu, M. B. Hershenson, T. Borbiev, and A. D. Verin
Pertussis toxin directly activates endothelial cell p42/p44 MAP kinases via a novel signaling pathway
Am J Physiol Cell Physiol,
May 1, 2001;
280(5):
C1233 - C1241.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Arnaud, V. Nicaud, O. Poirier, F. Rendu, M. Alhenc-Gelas, J.-N. Fiessinger, J. Emmerich, and M. Aiach
Protective Effect of a Thrombin Receptor (Protease-Activated Receptor 1) Gene Polymorphism Toward Venous Thromboembolism
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2000;
20(2):
585 - 592.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Verin, C. Cooke, M. Herenyiova, C. E. Patterson, and J. G. N. Garcia
Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses
Am J Physiol Lung Cell Mol Physiol,
October 1, 1998;
275(4):
L788 - L799.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Papapetropoulos, P. Piccardoni, G. Cirino, M. Bucci, R. Sorrentino, C. Cicala, K. Johnson, V. Zachariou, W. C. Sessa, and D. C. Altieri
Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling
PNAS,
April 14, 1998;
95(8):
4738 - 4742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ruan, H. Kan, J.-H. Parmentier, S. Fatima, L. F. Allen, and K. U. Malik
Alpha-1A Adrenergic Receptor Stimulation with Phenylephrine Promotes Arachidonic Acid Release by Activation of Phospholipase D in Rat-1 Fibroblasts: Inhibition by Protein Kinase A
J. Pharmacol. Exp. Ther.,
February 1, 1998;
284(2):
576 - 585.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
V. Natarajan, W. M. Scribner, and S. Vepa
Phosphatase Inhibitors Potentiate 4-Hydroxynonenal-induced Phospholipase D Activation in Vascular Endothelial Cells
Am. J. Respir. Cell Mol. Biol.,
August 1, 1997;
17(2):
251 - 259.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Y. Ruan, H. Kan, and K. U. Malik
J. Pharmacol. Exp. Ther.,
June 1, 1997;
281(3):
1038 - 1046.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Molino, M. J. Woolkalis, J. Reavey-Cantwell, D. Pratico, P. Andrade-Gordon, E. S. Barnathan, and L. F. Brass
Endothelial Cell Thrombin Receptors and PAR-2. TWO PROTEASE-ACTIVATED RECEPTORS LOCATED IN A SINGLE CELLULAR ENVIRONMENT
J. Biol. Chem.,
April 25, 1997;
272(17):
11133 - 11141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Marsen, M. S. Simonson, and M. J. Dunn
Thrombin Induces the Preproendothelin-1 Gene in Endothelial Cells by a Protein Tyrosine Kinase–Linked Mechanism
Circ. Res.,
June 1, 1995;
76(6):
987 - 995.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
X.-N. Li, V. K. Varma, J. M. Parks, R. L. Benza, J. C. Koons, J. R. Grammer, H. Grenett, E. M. Tabengwa, and F. M. Booyse
Thrombin Decreases the Urokinase Receptor and Surface-Localized Fibrinolysis in Cultured Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
March 1, 1995;
15(3):
410 - 419.
[Abstract]
[Full Text]
|
|
|
|
|
